Your session is about to expire
← Back to Search
FMT + SIMBA for Obsessive-Compulsive Disorder (FOCUSED Trial)
FOCUSED Trial Summary
This trial is studying if gut bacteria from healthy donors can help people with OCD. It will use stool analysis and SIMBA capsules to measure changes in the gut microbiome.
FOCUSED Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FOCUSED Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been on a steady dose of SSRI medication for 3 months.I have difficulty swallowing.I have fewer than 2 bowel movements a week.I have a blockage in my intestines.I have a weakened immune system.My current depression medication is not working well enough.I regularly take antibiotics, prebiotics, or probiotics.I have been diagnosed with IBD, Crohn's, Ulcerative colitis, or Celiac disease.I have been diagnosed with OCD.My current depression medication is not working well enough.
- Group 1: FMT capsule + SIMBA Capsule
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential adverse effects could arise from the combination of FMT capsule and SIMBA Capsule?
"The existing evidence on FMT capsule + SIMBA Capsule's safety is sufficient to warrant a score of 2. This Phase 2 trial has not yet produced any data regarding the medication's efficacy, but there are multiple studies indicating its safety profile."
Does the study requirements include elderly participants aged 85 and over?
"This clinical trial has a narrow age range of 18 to 65. However, there are additional studies dedicated specifically for those under 18 and over 65 respectively; 20 trials and 67 trials in total."
Are new participants still being sought for this scientific endeavor?
"As per clinicaltrials.gov, the recruitment for this medical trial has closed since the last changes made to it were on February 7th 2023. Nonetheless, there are currently 106 other trials actively searching for participants."
What are the desired outcomes of this experiment?
"The primary outcome metric for this Nimble Science Ltd.-sponsored study, evaluated over a 0-13 week period of time, is the Toronto Side Effects Scale (TSES). Additionally, secondary assessments will be conducted to gauge Global function/overall improvement; these include The General Anxiety Disorder-7 scale (GAD-7), Positive and Negative Affect Schedule (PANAS) as well as Patient Health Questionnaire-9(PHQ9)."
Am I eligible to enroll in this clinical experiment?
"This clinical trial is enrolling 20 individuals between the ages of 18 and 65 who have been diagnosed with Obsessive Compulsive Disorder (OCD). To be eligible, patients must also meet the following requirements: a confirmed OCD diagnosis, at least 12 weeks of SSRI treatment prior to baseline assessment, and evidence that their current medication has not adequately managed symptoms."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger